CoChat

How Patients View Probiotics: Findings From a Multicenter Study of Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome

Open access
Mercer, MaryBeth, Brinich, Margaret A., Geller, Gail, Harrison, Krista, Highland, Janelle, James, Katherine, Marshall, Patricia, McCormick, Jennifer B., Tilburt, Jon, Achkar, Jean-Paul, Farrell, Ruth M., Sharp, Richard R. · 2012 · Journal of Clinical Gastroenterology
Cited by 54

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) have access to a growing number of probiotic products marketed to improve digestive health. It is unclear how patients make decisions about probiotics and what role they expect their gastroenterologists to play as they consider using probiotics. Understanding patients' knowledge, attitudes and expectations of probiotics may help gastroenterologists engage patients in collaborative discussions about probiotics. STUDY: Focus groups were conducted with patients with IBD and IBS at the Cleveland Clinic, Mayo Clinic, and Johns Hopkins University. Inductive analytic methods were used to identify common themes and draw interpretations from focus group narratives. RESULTS: One hundred thirty-six patients participated in 22 focus groups between March and August 2009. Patients viewed probiotics as an appealing alternative to pharmaceutical drugs and understood probiotics as a more "natural," low-risk therapeutic option. Many patients were hesitant to use them without consulting their gastroenterologists. Patients would weigh the risks and benefits of probiotics, their disease severity and satisfaction with current treatments when considering probiotic use. CONCLUSIONS: Patients are interested in probiotics but have many unanswered questions about their use. Our findings suggest that patients with IBD and IBS will look to gastroenterologists and other clinicians as trustworthy advisors regarding the utility of probiotics as an alternative or supplement to pharmaceutical drugs. Gastroenterologists and other clinicians who care for patients with these diseases should be prepared to discuss the potential benefits and risks of probiotics and assist patients in making informed decisions about their use.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mcg.0b013e318225f545

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 54

Metadata

Authors
Mercer, M., Brinich, M. A., Geller, G., Harrison, K., Highland, J., James, K., Marshall, P., McCormick, J. B., Tilburt, J., Achkar, J.-P., Farrell, R. M., & Sharp, R. R.
Venue
Journal of Clinical Gastroenterology
Published
2012-02
Volume
46
Issue
2
Pages
138-144
ISSN
0192-0790 (ISSN-L)
OpenAlex
W2134180106
Cited by
54
References
3
FWCI
9.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How Patients View Probiotics: Findings From a Multicenter Study of Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome. https://app.cochat.ai/papers/10.1097/mcg.0b013e318225f545
The paper
Mercer, M., Brinich, M. A., Geller, G., Harrison, K., Highland, J., James, K., Marshall, P., McCormick, J. B., Tilburt, J., Achkar, J.-P., Farrell, R. M., & Sharp, R. R. (2012). How Patients View Probiotics: Findings From a Multicenter Study of Patients With Inflammatory Bowel Disease and Irritable Bowel Syndrome. Journal of Clinical Gastroenterology. https://doi.org/10.1097/mcg.0b013e318225f545

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.